Coloplast A/S - Allocation of Share Options
Yahoo FinanceFeb 9 10:18 ET
Coloplast A/S Goes Ex-dividend Tomorrow
Seeking AlphaDec 7, 2023 10:26 ET
Coloplast Target Raised to DKK925 From DKK830 by Jefferies
Coloplast Target Raised to DKK925 From DKK830 by Jefferies
Dow JonesNov 30, 2023 01:31 ET
COLOPLAST SPON ADS EACH REPR 0.1 OD SHS To Go Ex-Dividend On December 8th, 2023 With 0.23266 USD Dividend Per Share
November 17th - $COLOPLAST SPON ADS EACH REPR 0.1 OD SHS(CLPBY.US)$ is trading ex-dividend on December 8th, 2023. Shareholders of record on December 11th, 2023 will receive 0.23266 USD dividend pe
moomoo NewsNov 16, 2023 19:50 ET
Coloplast's Kerecis Buy Is Strategically Positive -- Market Talk
1135 GMT - Coloplast's acquisition of Kerecis is a strategic positive but will likely drive low single digit percentage consensus EPS dilution, Citi analysts Veronika Dubajova and Giang H Nguyen say i
Dow JonesJul 7, 2023 07:35 ET
Coloplast to Acquire Wound Care Firm Kerecis for $1.3B
Seeking AlphaJul 7, 2023 06:58 ET
Coloplast Raises Long-Term Organic Growth Guidance to 8%-10% From 7%-9%
Coloplast Raises Long-Term Organic Growth Guidance to 8%-10% From 7%-9%
Dow JonesJul 7, 2023 02:34 ET
Express News | Coloplast: Kerecis Has Developed Tech That Uses Fish Skin to Aid Wound Healing
Moomoo 24/7Jul 7, 2023 02:32 ET
Coloplast: Kerecis Is Biologics Wound Care Company
Coloplast: Kerecis Is Biologics Wound Care Company
Dow JonesJul 7, 2023 02:31 ET
Express News | Coloplast Agrees to Buy Kerecis For up to $1.3 Billion
Moomoo 24/7Jul 7, 2023 02:28 ET
Short Volatility Alert: Coloplast
On Tuesday, shares of Coloplast (OTC:CLPBY) experienced volatile short activity. After the activity, the stock price went up +0.59% to $13.18. The overall sentiment for CLPBY has been Bullish. The sig
BenzingaApr 5, 2023 11:04 ET
Express News | Coloplast Cut to Hold From Buy by Jefferies
Moomoo 24/7Sep 20, 2022 01:25 ET
Coloplast Target Cut to DKK880 From DKK1,150 by Jefferies
Coloplast Target Cut to DKK880 From DKK1,150 by Jefferies
Dow JonesSep 20, 2022 01:25 ET
Coloplast ASB Non-GAAP EPS of DKK5.78, revenue of DKK5.17B
Coloplast ASB press release (OTCPK:CLPBF): FQ1 Non-GAAP EPS of DKK5.78.Revenue of DKK5.17B (+9.1% Y/Y).
Seeking AlphaJan 25, 2022 11:22 ET
Coloplast Agrees to Buy Atos Medical From PAI Partners for EUR2.16 Bln
By Dominic Chopping Danish medical-device and services provider Coloplast AS said Monday that it has agreed to acquire Atos Medical from French private-equity firm PAI Partners in a deal wort
Dow Jones NewswiresNov 8, 2021 02:40 ET
No Data
No Data